624734-19-6 Usage
General Description
4H-PYRAN-4-ONE, 3-FLUOROTETRAHYDRO- is a chemical compound that belongs to the family of pyranones and is characterized by the presence of a fluorine atom and a tetrahydro group. It is a heterocyclic compound that is commonly used in organic synthesis and medicinal chemistry. The fluorine atom in the compound imparts unique properties such as increased stability and altered reactivity, making it useful in various chemical reactions. 4H-PYRAN-4-ONE, 3-FLUOROTETRAHYDRO- has also been studied for its potential pharmacological properties, including its effects on the central nervous system and its potential as an anti-inflammatory agent. Overall, 4H-PYRAN-4-ONE, 3-FLUOROTETRAHYDRO- has diverse applications in chemical and pharmaceutical industries due to its unique structure and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 624734-19-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,4,7,3 and 4 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 624734-19:
(8*6)+(7*2)+(6*4)+(5*7)+(4*3)+(3*4)+(2*1)+(1*9)=156
156 % 10 = 6
So 624734-19-6 is a valid CAS Registry Number.
InChI:InChI=1/C5H7FO2/c6-4-3-8-2-1-5(4)7/h4H,1-3H2
624734-19-6Relevant articles and documents
SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
-
, (2016/05/02)
Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.
SERINE/THREONINE KINASE INHIBITORS
-
Paragraph 0245-0246, (2014/03/25)
Compounds having the formula I wherein R2, X and Z as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for treating hyperproliferative disorders.
QUINAZOLINE COMPOUNDS AS SERINE/THREONINE KINASE INHIBITORS
-
Paragraph 00220, (2013/03/26)
Compounds having the formula (I) wherein R1, R2, R3 and Ar as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for treating hyperproliferative disorders.